Company Overview

Update
Founded:
2007
Founders:
Michael Gertner, Michael Gertner
Headquarters:
Newark, CA
Funding:
$92.1M
Categories:
Biotechnology
Description:
Oraya Therapeutics develops non-invasive robotically-controlled treatments for inflammatory and neovascular diseases of the eye.

Detailed Description

Update

Oraya Therapeutics is currently testing its first application of the IRay system. Oraya Therapeutics develops noninvasive robotically controlled treatments for inflammatory and neovascular diseases of the eye.

Current Team (8)

Update

Past Team (2)

Update

Board Members and Advisors (5)

Update

Investors (4)

Update

Offices/Locations (1)

Update
  • Office

    8000 Jarvis Ave.

    Newark, CA 94560

    USA

Images (1)

Update
  • 6b40ed0e789ef22e4979ad0871fdc93f